Healthcare Polish Community
Our community narratives are driven by numbers and valuation.
Healthcare Polish Investing Ideas
Cardiac marker could be a hit
In 5 years, the company should still be thriving, entering new markets and expanding in existing ones. Positive passage of the third stage of testing of a new cardiac marker could help.Read more
PH
zł204.19
40.3% overvalued intrinsic discount
Fair Value
Revenue
8.49% p.a.
Profit Margin
13%
Future PE
22x
Price in 2029
zł311.79
